Media Coverage
Suffering from cystic fibrosis and rejecting the transplanted lungs he had gotten just two years ago, Jon Sacker, 33, came to UPMC in Pittsburgh from his hometown in Moore, Oklahoma, as a last resort...
We are honored to have the Hemolung RAS recognized as a finalist for the 2014 MDEA Awards. This admission is the result of more than 10 years of dedication and persever...
By Matthew Pross, Publications Manager and Editor for the Pittsburgh Technology Council. Last year was a banner year for South Side-based ALung Technologies. The local li...
Press Releases
PITTSBURGH (February 27, 2018) - ALung Technologies, Inc., today announced that it has initiated patient enrollment in its VENT-AVOID Trial of the Hemolung RAS. The M...
PITTSBURGH (September 27, 2017) - ALung Technologies, Inc., today announced U.S. Food and Drug Administration (FDA) approval of its Investigational Device...
PITTSBURGH (April 25, 2017) - ALung Technologies, Inc., announced today the submission of its Investigational Device Exemption (IDE) application to t...